½ÃÀ庸°í¼­
»óǰÄÚµå
1620689

¼¼°èÀÇ ÇÃ¶ó½ºÆ½ ´ãµµ ½ºÅÙÆ® ½ÃÀå : Àç·á, ÇüÅÂ, ¿ëµµ, ÃÖÁ¾ »ç¿ëÀÚº° ¿¹Ãø(2025-2030³â)

Plastic Biliary Stents Market by Material (Ethylene Vinyl Acetate, Fluorinated Ethylene Propylene, Polyethylene), Shape (Angled, Bended/Curved, Pigtailed), Application, End User - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 184 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

ÇÃ¶ó½ºÆ½ ´ãµµ ½ºÅÙÆ® ½ÃÀåÀº 2023³â¿¡ 1¾ï 6,515¸¸ ´Þ·¯·Î Æò°¡µÇ¾úÀ¸¸ç, 2024³â¿¡´Â 1¾ï 7,295¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹»óµÇ¸ç CAGR 4.80%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 2¾ï 2,935¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ÇÃ¶ó½ºÆ½ ´ãµµ ½ºÅÙÆ®´Â ´ã°üÀÇ Æó»öÀ» ¿ÏÈ­ÇÏ´Â µ¥ »ç¿ëµÇ´Â ÀÇ·á±â±âÀ̸ç, ¾Ï¿¡ ÀÇÇÑ Æó»öÀ̳ª ´ãµµ °á¼® µîÀÇ È¯ÀÚ¿¡°Ô ÀÚÁÖ ¹ß»ýÇÒ Çʿ伺ÀÔ´Ï´Ù. Ȳ´Þ°ú ´ã°ü¿° ÇÕº´ÁõÀ» ¿¹¹æÇϰí ȯÀÚÀÇ QOL°ú ÀÓ»ó °á°ú¸¦ Çâ»ó½ÃŰ´Â Áß¿äÇÑ ¿ëµµÀÔ´Ï´Ù. ÇÃ¶ó½ºÆ½ ´ãµµ ÅÙÆ® ½ÃÀåÀ» °ßÀÎÇϰí ÀÖ´Â °ÍÀº ¼ÒÈ­°ü ÁúȯÀ̳ª °£ ÁúȯÀÇ ÀÌȯÀ² Áõ°¡, Àα¸ÀÇ °í·ÉÈ­, ±Ý¼Ó ½ºÅÙÆ®¿¡ ´ëÇÑ ÇÃ¶ó½ºÆ½ ½ºÅÙÆ®ÀÇ ºñ¿ë ´ëºñ È¿°úÀÔ´Ï´Ù. Áõ°¡°¡ ´õ¿í ½ÃÀå ¼ºÀå¿¡ ±â¿© ¾ð¸ÞÆ® ´ÏÁî°¡ ÀÖ´Â Áö¿ª¿¡¼­´Â ÀÇ·á ÀÎÇÁ¶ó¿¡ ´ëÇÑ ÅõÀÚ È®´ë°¡ ¼ö¿ä Áõ°¡·Î À̾îÁú ¼ö ÀÖÀ¸¸ç, ºñÁî´Ï½º ±âȸ°¡ ź»ýÇÕ´Ï´Ù. ÇÕº´ÁõÀÇ À§Çè°ú °úÁ¦µµ ÀÖ½À´Ï´Ù. °³Á¸ ±â°£ÀÌ ±æ°í ¹Ýº¹ ¼ö¼úÀÇ Çʿ伺ÀÌ ÀûÀº ±Ý¼Ó ½ºÅÙÆ®¿Í °°Àº ´ëü Àç·á¿ÍÀÇ °æÀïµµ °úÁ¦ÀÔ´Ï´Ù. ¿¬ÀåÀ»À§ÇÑ »õ·Î¿î ¾ø´Â Àç·á¿Í ÄÚÆÃÀÇ »ç¿ëÀ» ÅëÇØ ÇÃ¶ó½ºÆ½ ½ºÅÙÆ®ÀÇ »ýü ÀûÇÕ¼º°ú °³Á¸ ±â°£À» °³¼±ÇÏ´Â µ¥ ÃÊÁ¡À» ¸ÂÃâ ¼ö ÀÖ½À´Ï´Ù. Á¶»ç ¹× °ú°ÅÀÇ ¹ø°Å·Î¿òÀ» ¾ø¾Ö´Â »ýºÐÇØ¼º ½ºÅÙÆ®ÀÇ °³¹ßµµ ¼ºÀåÀ» °¡¼ÓÇÒ °¡´É¼ºÀÌ ÀÖ½À´Ï´Ù. ±× °á°ú, Áö¼Ó°¡´ÉÇÑ Ã·´Ü ÀÇ·á Àç·á¿¡ ÃÊÁ¡À» ¸ÂÃá º¥Ã³ ±â¾÷¿¡ Ȱ·Î°¡ ¿­¸®°í ÀÖ½À´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁسâ (2023³â) 1¾ï 6,515¸¸ ´Þ·¯
ÃßÁ¤³â (2024³â) 1¾ï 7,295¸¸ ´Þ·¯
¿¹Ãø³â(2030³â) 2¾ï 2,935¸¸ ´Þ·¯
CAGR(%) 4.80%

½ÃÀå ¿ªÇÐ: ºü¸£°Ô ÁøÈ­ÇÏ´Â ÇÃ¶ó½ºÆ½ ´ãµµ ½ºÅÙÆ® ½ÃÀåÀÇ ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ® °ø°³

ÇÃ¶ó½ºÆ½ ´ãµµ ½ºÅÙÆ® ½ÃÀåÀº ¼ö¿ä ¹× °ø±ÞÀÇ ¿ªµ¿Àû ÀÎ »óÈ£ ÀÛ¿ë¿¡ ÀÇÇØ º¯¸ðÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ½ÃÀå ¿ªÇÐÀÇ ÁøÈ­¸¦ ÀÌÇØÇÔÀ¸·Î½á ±â¾÷Àº ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÅõÀÚ°áÁ¤, Àü·«Àû °áÁ¤ Á¤¹ÐÈ­, »õ·Î¿î ºñÁî´Ï½º ±âȸ ȹµæ¿¡ ´ëºñÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ µ¿ÇâÀ» Á¾ÇÕÀûÀ¸·Î ÆÄ¾ÇÇÔÀ¸·Î½á ±â¾÷Àº Á¤Ä¡Àû, Áö¸®Àû, ±â¼úÀû, »çȸÀû, °æÁ¦Àû ¿µ¿ª¿¡ °ÉÄ£ ´Ù¾çÇÑ À§ÇèÀ» ¿ÏÈ­ÇÒ ¼ö ÀÖÀ¸¸ç, ¼ÒºñÀÚ Çൿ°ú ±×°ÍÀÌ Á¦Á¶ ºñ¿ë°ú ±¸¸Å µ¿Çâ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ»º¸´Ù ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • ¼¼°è Àα¸¿¡¼­ ´ãµµ ÁúȯÀÇ À¯º´·ü »ó½Â
    • ´ãµµ Áúȯ Ä¡·á¿¡ À־ÀÇ Àúħ½À ÀÇ·á¿¡ÀÇ ±âÈ£
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ÇÃ¶ó½ºÆ½ ´ãµµ ½ºÅÙÆ®ÀÇ ºÒÆíÇÑ ¸®ÄÝ
  • ½ÃÀå ±âȸ
    • ÇÃ¶ó½ºÆ½ ´ãµµ ½ºÅÙÆ®ÀÇ µðÀÚÀΰú Á¦Á¶ÀÇ Áøº¸
    • ÇÃ¶ó½ºÆ½ ´ãµµ ½ºÅÙÆ®ÀÇ »óȯ °³¼±
  • ½ÃÀåÀÇ °úÁ¦
    • ´ëü ½ºÅÙÆ®ÀÇ °¡¿ë¼º°ú ÇÃ¶ó½ºÆ½ ´ãµµ ½ºÅÙÆ®ÀÇ ÇÕº´Áõ

Porter's Five Force : ÇÃ¶ó½ºÆ½ ´ãµµ ½ºÅÙÆ® ½ÃÀåÀ» Ž»öÇÏ´Â Àü·« µµ±¸

Porter's Five Force Framework´Â ÇÃ¶ó½ºÆ½ ´ãµµ ½ºÅÙÆ® ½ÃÀå °æÀï ±¸µµ¸¦ ÀÌÇØÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ±â¾÷ÀÌ ½ÃÀå ³» ¼¼·Âµµ¸¦ Æò°¡ÇÏ°í ½Å±Ô »ç¾÷ÀÇ ¼öÀͼºÀ» ÆÇ´ÜÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ´õ °­ÀÎÇÑ ½ÃÀå¿¡¼­ Æ÷Áö¼Å´×À» º¸Àå ÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : ÇÃ¶ó½ºÆ½ ´ãµµ ½ºÅÙÆ® ½ÃÀå¿¡¼­ ¿ÜºÎ ¿µÇâÀ» ÆÄ¾Ç

¿ÜºÎ °Å½Ã ȯ°æ ¿äÀÎÀº ÇÃ¶ó½ºÆ½ ´ãµµ ½ºÅÙÆ® ½ÃÀåÀÇ ¼º°ú ¿ªÇÐÀ» Çü¼ºÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. ¿µÇâÀ» Ž»öÇÏ´Â µ¥ ÇÊ¿äÇÑ Á¤º¸¸¦ Á¦°øÇÕ´Ï´Ù. PESTLE ¿äÀÎÀ» Á¶»çÇÏ¸é ±â¾÷Àº ÀáÀçÀûÀÎ À§Çè°ú ±âȸ¸¦ ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ¾ÕÀ» ³»´Ùº» Àû±ØÀûÀÎ ÀÇ»ç°áÁ¤À» ÇÒ Áغñ°¡ µÇ¾î ÀÖ½À´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼® : ÇÃ¶ó½ºÆ½ ´ãµµ ½ºÅÙÆ® ½ÃÀå °æÀï ±¸µµ ÆÄ¾Ç

ÇÃ¶ó½ºÆ½ ´ãµµ ½ºÅÙÆ® ½ÃÀåÀÇ »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®À» ÅëÇØ °ø±Þ¾÷üÀÇ ¼º°ú¸¦ Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®À» ÅëÇØ ½ÃÀå ÁýÁß, ºÎ¹® È­ ¹× ÅëÇÕ µ¿ÇâÀ» ¹àÇô³»°í °ø±Þ¾÷ü´Â °æÀïÀÌ Ä¡¿­ ÇØÁü¿¡ µû¶ó ÀÚ»çÀÇ ÁöÀ§¸¦ ³ôÀÌ´Â Àü·«Àû ÀÇ»ç °áÁ¤À» ³»¸± Çʿ䰡 ÀÖ½À´Ï´Ù. Áö½ÄÀ» ¾òÀ» ¼ö ÀÖ½À´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º : ÇÃ¶ó½ºÆ½ ´ãµµ ½ºÅÙÆ® ½ÃÀå¿¡¼­ °ø±Þ¾÷üÀÇ ¼º´É Æò°¡

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â ÇÃ¶ó½ºÆ½ ´ãµµ ½ºÅÙÆ® ½ÃÀå¿¡¼­ º¥´õ¸¦ Æò°¡ÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. Á¤º¸¸¦ ±â¹ÝÀ¸·Î ÀÇ»ç °áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù. ³× °¡Áö »çºÐ¸éÀ» ÅëÇØ º¥´õ¸¦ ¸íÈ®Çϰí Á¤È®ÇÏ°Ô ºÐ·ùÇϰí Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê ¹× ¼Ö·ç¼ÇÀ» ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù.

Àü·« ºÐ¼® ¹× Ãßõ: ÇÃ¶ó½ºÆ½ ´ãµµ ½ºÅÙÆ® ½ÃÀå¿¡¼­ ¼º°øÀ» À§ÇÑ ±æÀ» ±×¸®±â

ÇÃ¶ó½ºÆ½ ´ãµµ ½ºÅÙÆ® ½ÃÀåÀÇ Àü·« ºÐ¼®Àº ¼¼°è ½ÃÀå¿¡¼­ÀÇ ÇöÀå °­È­¸¦ ¸ñÇ¥·Î ÇÏ´Â ±â¾÷¿¡ ÇʼöÀûÀÔ´Ï´Ù. ÀÌ Á¢±Ù¹ýÀ» ÅëÇØ °æÀï ±¸µµ¿¡¼­ °úÁ¦¸¦ ±Øº¹ÇÏ°í »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Ȱ¿ëÇÏ¿© Àå±âÀûÀÎ ¼º°øÀ» °ÅµÑ ¼ö Àִ üÁ¦¸¦ ±¸ÃàÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â ÁÖ¿ä °ü½É ºÐ¾ß¸¦ ´Ù·ç´Â ½ÃÀå¿¡ ´ëÇÑ Á¾ÇÕÀûÀÎ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

1. ½ÃÀå ħÅõ: ÇöÀç ½ÃÀå ȯ°æÀÇ »ó¼¼ÇÑ °ËÅä, ÁÖ¿ä ±â¾÷ÀÇ ±¤¹üÀ§ÇÑ µ¥ÀÌÅÍ, ½ÃÀå µµ´Þ¹üÀ§ ¹× Àü¹ÝÀûÀÎ ¿µÇâ·ÂÀ» Æò°¡ÇÕ´Ï´Ù.

2. ½ÃÀå °³Ã´µµ: ½ÅÈï ½ÃÀåÀÇ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇϰí, ±âÁ¸ ºÎ¹®¿¡¼­ÀÇ È®Àå °¡´É¼ºÀ» Æò°¡Çϸç, ¹Ì·¡ ¼ºÀåÀ» À§ÇÑ Àü·«Àû ·Îµå¸ÊÀ» ¼³¸íÇÕ´Ï´Ù.

3. ½ÃÀå ´Ù¾çÈ­: ÃÖ±Ù Á¦Ç° Ãâ½Ã, ¹Ì°³Ã´ Áö¿ª, »ê¾÷ÀÇ ÁÖ¿ä Áøº¸, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4. °æÀï Æò°¡ ¹× Á¤º¸ : °æÀï ±¸µµ¸¦ öÀúÈ÷ ºÐ¼®ÇÏ¿© ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦ ´ç±¹ ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ±â¼ú Áøº¸ µîÀ» °ËÁõÇÕ´Ï´Ù.

5. Á¦Ç° °³¹ß ¹× Çõ½Å : ¹Ì·¡ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÃÖ÷´Ü ±â¼ú, R&D Ȱµ¿, Á¦Ç° Çõ½ÅÀ» °­Á¶ÇÕ´Ï´Ù.

¶ÇÇÑ ÀÌÇØ°ü°èÀÚ°¡ ÃæºÐÇÑ Á¤º¸¸¦ ¾òÀº ÈÄ ÀÇ»ç°áÁ¤ÇÒ ¼ö ÀÖµµ·Ï Áß¿äÇÑ Áú¹®¿¡µµ ´ë´äÇϰí ÀÖ½À´Ï´Ù.

1. ÇöÀç ½ÃÀå ±Ô¸ð¿Í ÇâÈÄ ¼ºÀå ¿¹ÃøÀº?

2. ÃÖ°íÀÇ ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, Áö¿ªÀº ¾îµðÀԴϱî?

3. ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ°ú ±ÔÁ¦ÀÇ ¿µÇâÀº?

4. ÁÖ¿ä º¥´õÀÇ ½ÃÀå Á¡À¯À²°ú °æÀï Æ÷Áö¼ÇÀº?

5. º¥´õ ½ÃÀå ÁøÀÔ¡¤Ã¶¼ö Àü·«ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÍ¿ø°ú Àü·«Àû ±âȸ´Â ¹«¾ùÀΰ¡?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
      • ¼¼°è Àα¸¿¡ À־ÀÇ ´ãµµ ÁúȯÀÇ ÀÌȯÀ²ÀÇ »ó½Â
      • ´ãµµ ÁúȯÀÇ Ä¡·á¿¡´Â Àúħ½À ÀÇ·á óġ°¡ ¹Ù¶÷Á÷ÇÏ´Ù
    • ¾ïÁ¦¿äÀÎ
      • ÇÃ¶ó½ºÆ½ ´ãµµ ½ºÅÙÆ®ÀÇ ¾Ç¿µÇâÀÇ »ý°¢
    • ±âȸ
      • ÇÃ¶ó½ºÆ½ ´ãµµ ½ºÅÙÆ®ÀÇ µðÀÚÀΰú Á¦ÀÛÀÇ Áøº¸
      • ÇÃ¶ó½ºÆ½ ´ãµµ ½ºÅÙÆ® ȯºÒ °³¼±
    • °úÁ¦
      • ´ëü ½ºÅÙÆ®ÀÇ °¡¿ë¼º°ú ÇÃ¶ó½ºÆ½ ´ãµµ ½ºÅÙÆ®ÀÇ ÇÕº´Áõ
  • ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®
    • Àç·á : ½ºÅÙÆ®ÀÇ ºÎÀÛ¿ëÀ» ¾ïÁ¦Çϰí Àå±â¿ÍÀÇ ÀûÇÕ¼ºÀ» Çâ»ó½Ã۱â À§ÇØ ºÒ¼ÒÈ­ ¿¡Æ¿·» ÇÁ·ÎÆÄÀÏ·»À» ¸¹ÀÌ »ç¿ë
    • ÇüÅÂ: Á¤È®ÇÑ Àü°³¿Í °üÀÇ ¸¸°î¿¡ÀÇ ÀûÇÕ¼º ¶§¹®¿¡ °¢µµ ½ºÅÙÆ®°¡ ¼±È£µÈ´Ù
    • ÃÖÁ¾ »ç¿ëÀÚ : º´¿øÀÇ °í±Þ ±â´É°ú ¸ÂÃãÇü ¼Ö·ç¼ÇÀ» °®Ãá ÇÃ¶ó½ºÆ½ ´ãµµ ½ºÅÙÆ®ÀÇ ¿ä±¸
    • ¿ëµµ : ´ã°ü ½ºÅÙÆ®´Â Á¦°Å°¡ ¿ëÀÌÇϱ⠶§¹®¿¡ ´ã°ü ´©ÃâÀÇ °ü¸®¿¡ À¯È¿
  • Porter's Five Forces ºÐ¼®
  • PESTEL ºÐ¼®
    • Á¤Ä¡
    • °æÁ¦
    • »çȸ
    • ±â¼ú
    • ¹ý·ü
    • ȯ°æ

Á¦6Àå ÇÃ¶ó½ºÆ½ ´ãµµ ½ºÅÙÆ® ½ÃÀå : Àç·áº°

  • ¼Ò°³
  • ¿¡Æ¿·» ºñ´Ò ¾Æ¼¼Å×ÀÌÆ®
  • ºÒ¼ÒÈ­ ¿¡Æ¿·» ÇÁ·ÎÆÄÀÏ·»
  • Æú¸®¿¡Æ¿·»
  • Æú¸®¿ì·¹Åº
  • Å×Ç÷Ð

Á¦7Àå ÇÃ¶ó½ºÆ½ ´ãµµ ½ºÅÙÆ® ½ÃÀå : Çüź°

  • ¼Ò°³
  • °¢Çü
  • °î¼±
  • ÇDZ×Å×ÀÏ
    • ´õºí ÇDZ×Å×ÀÏ
    • ½Ì±Û ÇDZ×Å×ÀÏ
  • ½ºÆ®·¹ÀÌÆ®

Á¦8Àå ÇÃ¶ó½ºÆ½ ´ãµµ ½ºÅÙÆ® ½ÃÀå : ¿ëµµº°

  • ¼Ò°³
  • ´ãÁó ´©Ãâ
  • ´ã¼®
  • Á¾¾ç

Á¦9Àå ÇÃ¶ó½ºÆ½ ´ãµµ ½ºÅÙÆ® ½ÃÀå : ÃÖÁ¾ »ç¿ëÀÚº°

  • ¼Ò°³
  • ¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC)
  • º´¿ø

Á¦10Àå ¾Æ¸Þ¸®Ä« ÇÃ¶ó½ºÆ½ ´ãµµ ½ºÅÙÆ® ½ÃÀå

  • ¼Ò°³
  • ¾Æ¸£ÇîÆ¼³ª
  • ºê¶óÁú
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ¹Ì±¹

Á¦11Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ÇÃ¶ó½ºÆ½ ´ãµµ ½ºÅÙÆ® ½ÃÀå

  • ¼Ò°³
  • È£ÁÖ
  • Áß±¹
  • Àεµ
  • Àεµ³×½Ã¾Æ
  • ÀϺ»
  • ¸»·¹À̽þÆ
  • Çʸ®ÇÉ
  • ½Ì°¡Æ÷¸£
  • Çѱ¹
  • ´ë¸¸
  • ű¹
  • º£Æ®³²

Á¦12Àå À¯·´¡¤Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ÇÃ¶ó½ºÆ½ ´ãµµ ½ºÅÙÆ® ½ÃÀå

  • ¼Ò°³
  • µ§¸¶Å©
  • ÀÌÁýÆ®
  • Çɶõµå
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • À̽º¶ó¿¤
  • ÀÌÅ»¸®¾Æ
  • ³×´ú¶õµå
  • ³ªÀÌÁö¸®¾Æ
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • īŸ¸£
  • ·¯½Ã¾Æ
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«
  • ½ºÆäÀÎ
  • ½º¿þµ§
  • ½ºÀ§½º
  • ÅÍŰ
  • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
  • ¿µ±¹

Á¦13Àå °æÀï ±¸µµ

  • ½ÃÀå Á¡À¯À² ºÐ¼®, 2023³â
  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º, 2023³â
  • °æÀï ½Ã³ª¸®¿À ºÐ¼®
    • ÀÇ·á±â¼ú±â¾÷ Medtronic, ÇÏÀ̵¥¶ó¹Ùµå ¿¬±¸°³¹ß¼¾ÅÍ¿¡ 300¾ï ·çÇǸ¦ ÅõÀÚ
    • Olympus, Çѱ¹ÀÇ ¼ÒÈ­°ü ½ºÅÙÆ® Á¦Á¶¾÷ü, Taewoong Medical Co., Ltd.¸¦ Àμö
  • Àü·« ºÐ¼®°ú Á¦¾È

±â¾÷ ¸ñ·Ï

  • Abbott Laboratories
  • Ace Medical Devices Pvt. Ltd.
  • Advin Health Care
  • Bassil Scientific Private Limited
  • Boston Scientific Corporation
  • Commed Corporation
  • Cook Group Inc.
  • Diagmed Healthcare Ltd.
  • Duomed Group
  • ELLA-CS, sro
  • ENDO-FLEX GmbH
  • Focuz Medical
  • Hobbs Medical Inc.
  • JDmeditech
  • Leufen Medical GmbH
  • Medorah Meditek Pvt. Ltd.
  • Medtronic PLC
  • Merit Medical Systems
  • Micro-Tech(Nanjing) Co., Ltd.
  • Olympus Corporation
  • Q3 Medical Devices Limited
  • Surgimedex
JHS 25.01.06

The Plastic Biliary Stents Market was valued at USD 165.15 million in 2023, expected to reach USD 172.95 million in 2024, and is projected to grow at a CAGR of 4.80%, to USD 229.35 million by 2030.

Plastic biliary stents are medical devices used to alleviate obstructions in bile ducts, a necessity often arising in patients with conditions like cancer-induced blockages or biliary stones. These stents restore bile flow, preventing complications like jaundice or cholangitis, marking their critical application in enhancing patient quality of life and clinical outcomes. The end-use scope typically spans hospitals, specialty clinics, and ambulatory surgical centers due to the procedural nature of stent placements. The market for plastic biliary stents is driven by the increasing incidence of gastrointestinal and liver diseases, aging populations, and the cost-effectiveness of plastic over metallic stents. Advancements in minimally invasive surgical techniques and rising healthcare expenditure further contribute to market growth. Opportunities emerge in regions with unmet healthcare needs, where increasing healthcare infrastructure investment can lead to heightened demand. However, the market faces challenges such as limited long-term stent patency and the risk of infections or procedural complications. Competition from alternative materials like metal stents, which offer longer patency and reduced need for repeated procedures, poses another challenge. Innovations could focus on improving the biocompatibility and patency duration of plastic stents, perhaps through the use of novel materials or coatings to reduce biofilm formation and increase longevity. Research into stent design that facilitates easier, less invasive placement and removal could also drive growth, along with developing biodegradable options to eliminate the need for follow-up extraction. Insight into the market indicates it is leaning towards greater emphasis on patient-centric solutions and cost-effective healthcare delivery, thereby opening avenues for ventures focusing on sustainable and advanced medicinal materials. Business growth could stem from strategic partnerships with healthcare providers and leveraging technology to enhance procedural success rates.

KEY MARKET STATISTICS
Base Year [2023] USD 165.15 million
Estimated Year [2024] USD 172.95 million
Forecast Year [2030] USD 229.35 million
CAGR (%) 4.80%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Plastic Biliary Stents Market

The Plastic Biliary Stents Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising prevalence of biliary tract diseases among global population
    • Preference for minimally invasive medical procedures for biliary tract disease treatment
  • Market Restraints
    • Adverse recalls of plastic biliary stents
  • Market Opportunities
    • Advancements in the designs and making of plastic biliary stents
    • Improvements in reimbursement for plastic biliary stents
  • Market Challenges
    • Availability of alternative stents and complications of plastic biliary stents

Porter's Five Forces: A Strategic Tool for Navigating the Plastic Biliary Stents Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Plastic Biliary Stents Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Plastic Biliary Stents Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Plastic Biliary Stents Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Plastic Biliary Stents Market

A detailed market share analysis in the Plastic Biliary Stents Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Plastic Biliary Stents Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Plastic Biliary Stents Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Plastic Biliary Stents Market

A strategic analysis of the Plastic Biliary Stents Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Plastic Biliary Stents Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Ace Medical Devices Pvt. Ltd., Advin Health Care, Bassil Scientific Private Limited, Boston Scientific Corporation, Conmed Corporation, Cook Group Inc., Diagmed Healthcare Ltd., Duomed Group, ELLA - CS, s.r.o., ENDO-FLEX GmbH, Focuz Medical, Hobbs Medical Inc., JDmeditech, Leufen Medical GmbH, Medorah Meditek Pvt. Ltd., Medtronic PLC, Merit Medical Systems, Micro-Tech (Nanjing) Co., Ltd., Olympus Corporation, Q3 Medical Devices Limited, and Surgimedex.

Market Segmentation & Coverage

This research report categorizes the Plastic Biliary Stents Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Material, market is studied across Ethylene Vinyl Acetate, Fluorinated Ethylene Propylene, Polyethylene, Polyurethane, and Teflon.
  • Based on Shape, market is studied across Angled, Bended/Curved, Pigtailed, and Straight. The Pigtailed is further studied across Double Pigtailed and Single Pigtailed.
  • Based on Application, market is studied across Biliary leaks, Gallstones, and Tumor.
  • Based on End User, market is studied across Ambulatory Surgical Centres and Hospitals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of biliary tract diseases among global population
      • 5.1.1.2. Preference for minimally invasive medical procedures for biliary tract disease treatment
    • 5.1.2. Restraints
      • 5.1.2.1. Adverse recalls of plastic biliary stents
    • 5.1.3. Opportunities
      • 5.1.3.1. Advancements in the designs and making of plastic biliary stents
      • 5.1.3.2. Improvements in reimbursement for plastic biliary stents
    • 5.1.4. Challenges
      • 5.1.4.1. Availability of alternative stents and complications of plastic biliary stents
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Material: High adoption of fluorinated ethylene propylene to manage adverse reactions of stents and offer improved compatibility with organs
    • 5.2.2. Shape: Preference for angled stents owing to their precise deployment and conformability to ductal curvatures
    • 5.2.3. End-User: Need for plastic biliary stents with advanced features or customized solutions in hospitals
    • 5.2.4. Application: Effective use of biliary stents to manage biliary leaks due to their easy removability
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Plastic Biliary Stents Market, by Material

  • 6.1. Introduction
  • 6.2. Ethylene Vinyl Acetate
  • 6.3. Fluorinated Ethylene Propylene
  • 6.4. Polyethylene
  • 6.5. Polyurethane
  • 6.6. Teflon

7. Plastic Biliary Stents Market, by Shape

  • 7.1. Introduction
  • 7.2. Angled
  • 7.3. Bended/Curved
  • 7.4. Pigtailed
    • 7.4.1. Double Pigtailed
    • 7.4.2. Single Pigtailed
  • 7.5. Straight

8. Plastic Biliary Stents Market, by Application

  • 8.1. Introduction
  • 8.2. Biliary leaks
  • 8.3. Gallstones
  • 8.4. Tumor

9. Plastic Biliary Stents Market, by End User

  • 9.1. Introduction
  • 9.2. Ambulatory Surgical Centres
  • 9.3. Hospitals

10. Americas Plastic Biliary Stents Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Plastic Biliary Stents Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Plastic Biliary Stents Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Medical Tech Firm Medtronic to Invest INR 3,000 Crore for Hyderabad R&D Center
    • 13.3.2. Olympus Will Acquire the Korean Gastrointestinal Stent Company Taewoong Medical Co., Ltd.
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Ace Medical Devices Pvt. Ltd.
  • 3. Advin Health Care
  • 4. Bassil Scientific Private Limited
  • 5. Boston Scientific Corporation
  • 6. Conmed Corporation
  • 7. Cook Group Inc.
  • 8. Diagmed Healthcare Ltd.
  • 9. Duomed Group
  • 10. ELLA - CS, s.r.o.
  • 11. ENDO-FLEX GmbH
  • 12. Focuz Medical
  • 13. Hobbs Medical Inc.
  • 14. JDmeditech
  • 15. Leufen Medical GmbH
  • 16. Medorah Meditek Pvt. Ltd.
  • 17. Medtronic PLC
  • 18. Merit Medical Systems
  • 19. Micro-Tech (Nanjing) Co., Ltd.
  • 20. Olympus Corporation
  • 21. Q3 Medical Devices Limited
  • 22. Surgimedex
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦